Use of Immunotherapeutic Expanded to Fifth Type of Cancer
The FDA has approved nivolumab for treating patients with recurrent or metastatic squamous cell carcinoma of the head...
Tag: SCCHN
The FDA has approved nivolumab for treating patients with recurrent or metastatic squamous cell carcinoma of the head...